Mitsubishi UFJ Trust & Banking’s Theravance Biopharma TBPH Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$430K	Buy	+25,282	New	+$419K	﹤0.01%	1110

Other funds holding TBPH

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SSA

Sierra Summit Advisors Incline Village, Nevada $895M AUM 106% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

MCC

Money Concepts Capital Palm Beach Gardens, Florida $2.16B AUM 28.67% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's TBPH Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Theravance Biopharma (TBPH) in Q2 2026: 25,282 shares worth $430K. The stake represents ﹤0.01% of the portfolio and ranks #1110 among its holdings.

46 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 25,282 shares of Theravance Biopharma worth $430K as of Q2 2026.
Theravance Biopharma was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
Theravance Biopharma made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1110 holding.
46 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.